中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Immune Diseases
Exploratory Indications
Pipeline
Pipeline
Clinical Trials
Partnership
Investors
Financials & Filing
Upcoming Events
Corporate presentation
SCIENTIFIC PRESENTATIONS
News
Careers
Investors
Financials & Filing
Upcoming Events
Corporate presentation
SCIENTIFIC PRESENTATIONS
2026
2025
2024
2023
2022
2021
2020
2019
2018
2026
2025
2024
2023
2022
2021
2020
2019
2018
Next Day Disclosure Returns - Share Buyback
2023-10-17
Next Day Disclosure Returns - Share Buyback
2023-10-16
Next Day Disclosure Returns - Share Buyback
2023-10-12
Next Day Disclosure Returns - Share Buyback
2023-10-11
Voluntary Announcement - Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023
2023-10-11
Next Day Disclosure Returns - Share Buyback
2023-10-10
Next Day Disclosure Returns - Share Buyback
2023-10-09
Next Day Disclosure Returns - Share Buyback
2023-10-06
Next Day Disclosure Returns - Share Buyback
2023-10-05
Next Day Disclosure Returns - Share Buyback
2023-10-04
«
5
6
7
8
»